Matches in Wikidata for { <http://www.wikidata.org/entity/Q74279091> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q74279091 description "clinical trial" @default.
- Q74279091 description "ensayu clínicu" @default.
- Q74279091 description "klinisch onderzoek" @default.
- Q74279091 description "клінічне випробування" @default.
- Q74279091 name "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)" @default.
- Q74279091 name "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis" @default.
- Q74279091 type Item @default.
- Q74279091 label "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)" @default.
- Q74279091 label "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis" @default.
- Q74279091 prefLabel "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)" @default.
- Q74279091 prefLabel "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis" @default.
- Q74279091 P1050 Q74279091-DD65EFA3-5CAD-412C-A5DD-D98EDD4E126C @default.
- Q74279091 P1050 Q74279091-DFBB5069-B634-42F5-8A07-48282529DDD3 @default.
- Q74279091 P1132 Q74279091-625AB0FB-6A9F-4E2F-8994-795B042E4637 @default.
- Q74279091 P1476 Q74279091-654E1747-FE2D-4EA2-8514-7333DA343193 @default.
- Q74279091 P17 Q74279091-E373D7A2-ECDC-470C-AAE3-BF79D703E52F @default.
- Q74279091 P1813 Q74279091-921FA82A-6AEF-4733-8F8F-4BDA90D3236D @default.
- Q74279091 P2899 Q74279091-31814F65-645E-42F3-92EB-CFB84E71B699 @default.
- Q74279091 P3098 Q74279091-741C87FB-C979-483B-9803-1D9D5C6E9D8E @default.
- Q74279091 P31 Q74279091-AFD9D206-3D18-417C-BBCB-4A826227F48E @default.
- Q74279091 P4135 Q74279091-59642406-EFE0-4DB8-A870-4FAA21DF3CDF @default.
- Q74279091 P4844 Q74279091-BC266A62-136E-4FF3-B81F-563843C59D13 @default.
- Q74279091 P4844 Q74279091-E9817377-3FB9-4A18-955A-0730B10837BB @default.
- Q74279091 P580 Q74279091-499DFD21-C346-42A6-B515-48096400CBAA @default.
- Q74279091 P582 Q74279091-DC8B9A03-CB58-49E6-AFCD-4C28FFB69072 @default.
- Q74279091 P6099 Q74279091-7FFEDCB7-90A3-4808-894B-2394AB8992E9 @default.
- Q74279091 P767 Q74279091-818210CD-C83E-45A8-AC62-FA9770494C78 @default.
- Q74279091 P767 Q74279091-9A7103B5-EDE9-4674-8D7A-B04396283D29 @default.
- Q74279091 P767 Q74279091-A5ACD569-3F86-43E2-A052-3EADEB3C3781 @default.
- Q74279091 P8363 Q74279091-3E57E9FF-9956-4489-A8E8-4EF3F9C98A2E @default.
- Q74279091 P859 Q74279091-0A8B59A8-B18A-4408-8D57-29BD09C051FC @default.
- Q74279091 P1050 Q140067 @default.
- Q74279091 P1050 Q8277 @default.
- Q74279091 P1132 "+264" @default.
- Q74279091 P1476 "Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS) A Prospective Randomized Open-label Blinded Endpoint (PROBE) Multicenter Non-inferiority Study" @default.
- Q74279091 P17 Q20 @default.
- Q74279091 P1813 "NOR-MS" @default.
- Q74279091 P2899 "+18" @default.
- Q74279091 P3098 "NCT04121403" @default.
- Q74279091 P31 Q30612 @default.
- Q74279091 P4135 "+65" @default.
- Q74279091 P4844 Q412323 @default.
- Q74279091 P4844 Q414030 @default.
- Q74279091 P580 "2019-10-01T00:00:00Z" @default.
- Q74279091 P582 "2023-07-01T00:00:00Z" @default.
- Q74279091 P6099 Q42824827 @default.
- Q74279091 P767 Q386372 @default.
- Q74279091 P767 Q486156 @default.
- Q74279091 P767 Q7923433 @default.
- Q74279091 P8363 Q78089383 @default.
- Q74279091 P859 Q3111191 @default.